200
Participants
Start Date
September 30, 2011
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
Mycophenolate mofetil
Tablets. For HLA-identical sibling donors:15 mg/kg t.i.d from day 0 to day 28. For alternative donor: 15 mg/kg, from day 0 to day 42.
Sirolimus
Tablets. 6 mg loading dose on day -3, followed by (1)-2 mg daily to a target trough level of 5 to 10 ng/mL. Full doses will be given until day 100 (sibling recipients) or 180 (alternative donor recipients). Doses will then be progressively tapered to be definitely discontinued by day 180 (sibling donors) or 365 (alternative donor recipients) in the absence of GVHD.
Jules Bordet Institute, Brussels
Queen Fabiola Children's University Hospital, Brussels
AZ VUB Jette, Brussels
Cliniques universitaires Saint-Luc- Université Catholique de Louvain, Brussels
Ziekenhuis Netwerk Antwerpen (ZNA), Antwerp
University Hospital, Antwerp, Edegem
University Hospital, Gasthuisberg, Leuven
CHU Sart Tilman, Liège
Cliniques Universitaires de Mont-Godinne, Yvoir
Jolimont Hospital Haine Saint Paul, Haine St-Paul
AZ Sint-Jan AV, Bruges
H.-Hart Hospital Roeselare-Menen, Roeselare
UZ Gent, Ghent
Collaborators (2)
AZ Sint-Jan AV
OTHER
Ziekenhuis Netwerk Antwerpen (ZNA)
OTHER
Jules Bordet Institute
OTHER
University Hospital, Gasthuisberg
OTHER
AZ-VUB
OTHER
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
OTHER
University Hospital, Antwerp
OTHER
Cliniques Universitaires de Mont-Godinne
UNKNOWN
Hospital de Jolimont
UNKNOWN
University Hospital, Ghent
OTHER
AZ Delta
OTHER
University of Liege
OTHER